CUSIP: 72940R102
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,337,681
-
Share change
-
+707,209
-
Total reported value
-
$5,551,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.28
-
Number of holders
-
28
-
Value change
-
+$914,031
-
Number of buys
-
14
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q2 2017
As of 30 Jun 2017,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,337,681 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, MENORA MIVTACHIM HOLDINGS LTD., UBS Group AG, JANE STREET GROUP, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Harel Insurance Investments & Financial Services Ltd., HighTower Advisors, LLC, ETF MANAGERS GROUP, LLC, Mount Lucas Management LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.